Page last updated: 2024-08-25

chitosan and Dry Eye

chitosan has been researched along with Dry Eye in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Han, Z; Yu, F; Zhang, AY; Zheng, M1
Bračko, D; Crespo Moral, M; Diebold, Y; Filipović-Grčić, J; Juretić, M; Jurišić Dukovski, B; Lovrić, J; Pepić, I; Randjelović, D; Savić, S1
Hoeller, S; Knoetzl, W; Nepp, J; Prinz, A; Prinz, M1
Baumgartner, R; Garhöfer, G; Höller, S; Kaya, S; O'Rourke, M; Peterson, W; Prinz, M; Schmetterer, L; Schmidl, D; Unterhuber, A; Werkmeister, R; Witkowska, KJ; Wolter, A1
Dua, HS; Messina, M1
Gong, L; Lin, T; Lu, Y; Wei, C; Zhang, X1
Cazarim, MS; Cruz-Cazarim, ELC; Lopez, RFV; Ogunjimi, AT; Petrilli, R; Rocha, EM1
Chae, JJ; Chuck, RS; Hongyok, T; Li, L; Na, D; Shin, YJ1

Trials

2 trial(s) available for chitosan and Dry Eye

ArticleYear
A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2017, Volume: 33, Issue:5

    Topics: Acetylcysteine; Adult; Chitosan; Cohort Studies; Double-Blind Method; Dry Eye Syndromes; Female; Humans; Male; Tears; Tomography, Optical Coherence

2017
Treatment of dry eye by intracanalicular injection of a thermosensitive chitosan-based hydrogel: evaluation of biosafety and availability.
    Biomaterials science, 2018, Nov-20, Volume: 6, Issue:12

    Topics: Adult; Animals; Cells, Cultured; Chitosan; Dry Eye Syndromes; Female; Humans; Hydrogels; Injections, Intraocular; Male; Middle Aged; Rabbits

2018

Other Studies

6 other study(ies) available for chitosan and Dry Eye

ArticleYear
A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 12-10, Volume: 315

    Topics: Animals; Antioxidants; Cerium; Chitosan; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Mice; Mice, Inbred C57BL; Nanoparticles; Reactive Oxygen Species; Solubility; Superoxide Dismutase; Tears

2019
Functional ibuprofen-loaded cationic nanoemulsion: Development and optimization for dry eye disease treatment.
    International journal of pharmaceutics, 2020, Feb-25, Volume: 576

    Topics: Animals; Cations; Cell Line; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Drug Stability; Dry Eye Syndromes; Emulsions; Female; Humans; Ibuprofen; Lecithins; Male; Nanoparticles; Particle Size; Solubility; Surface-Active Agents; Swine; Viscosity

2020
Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series.
    International ophthalmology, 2020, Volume: 40, Issue:6

    Topics: Acetylcysteine; Adult; Aged; Chitosan; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Tears; Treatment Outcome; Young Adult

2020
Early results on the use of chitosan-N-acetylcysteine (Lacrimera
    International ophthalmology, 2019, Volume: 39, Issue:3

    Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chitosan; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Keratitis; Lubricant Eye Drops; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Time Factors; Treatment Outcome

2019
Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2019, Volume: 140

    Topics: Administration, Topical; Animals; Chitosan; Cornea; Corneal Injuries; Diabetes Mellitus, Experimental; Dry Eye Syndromes; Epithelium, Corneal; Humans; Insulin; Lacrimal Apparatus; Male; Ophthalmic Solutions; Poloxamer; Prospective Studies; Rats; Rats, Wistar; Tears

2019
Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:4

    Topics: Acetylcysteine; Administration, Topical; Animals; Blinking; Botulinum Toxins; Botulinum Toxins, Type A; Chitosan; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescent Antibody Technique, Indirect; Fluorometholone; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tears

2009